This contract involves the delivery of medicinal products. Detailed specifications of the required products are provided in Annex 2 of the procurement documents. The total value of the contract is approximately €22,483,413.96. This opportunity is offered by the Białystok Oncology Center in Poland, a
Contract awarded. Originally published 1 year ago.
No single supplier dominates the field.
In healthcare medical, BIAYSTOK ONCOLOGY CENTER NAMED AFTER MARIE CURIE IN BIAYSTOK has awarded 8 contracts to 8 suppliers.
+2 more suppliers
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract opportunity involves the supply of equipment, software, and licenses as part of the digital transformation of the Białystok Oncology Center. The project is divided into several parts: Part 1 includes the delivery, migration, and implementation of the email management system for the cen
This contract involves the supply of medicinal products. Detailed specifications of the required products can be found in Annex 2 of the procurement documents.
This contract involves the design and execution of construction work to adapt the building formerly used by the CZMiS at 23 Ogrodowa Street for the needs of the Białystok Oncology Center (BCO). The project includes the construction of an underground connector for communication with the BCO hospital
This contract involves the supply of medicinal products. Detailed specifications of the required products can be found in Annex 2 of the procurement documents.
Develop medical countermeasures for CBRN threats with up to £4 million funding over 30 months, from prototype through Phase 2a clinical studies.
Cardiff and Vale University Health Board is seeking qualified providers to deliver outsourced orthopaedic surgical procedures through a competitive mini-competition process.
St George's University Hospitals NHS Foundation Trust is seeking a supplier to provide comprehensive Non-Invasive Prenatal Testing services, including equipment, reagents, software, and maintenance for approximately 5,000 annual patient tests, with a contract starting March/April 2027 and an initial 2-year term with optional extensions.
Opportunity to provide outsourced ADHD and ASD assessment and diagnostic evaluation services.
